Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

J Eugen-Olsen, O Andersen, A Linneberg, S Ladelund, T W Hansen, A Langkilde, Janne Petersen, T Pielak, L N Møller, Jakob Jeppesen, S Lyngbæk, M Fenger, M H Olsen, P R Hildebrandt, Knut Borch-Johnsen, T Jørgensen, Steen B Haugaard

293 Citationer (Scopus)

Abstrakt

Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
OriginalsprogEngelsk
TidsskriftJournal of Internal Medicine
Vol/bind268
Udgave nummer3
Sider (fra-til)296-308
Antal sider13
ISSN0954-6820
DOI
StatusUdgivet - 1 sep. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population'. Sammen danner de et unikt fingeraftryk.

Citationsformater